Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product PALO ALTO, Calif. — Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has established low immunoreaction risk GMP iPSCs derived from type O female blood and […]
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation “New BD,” built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of health care Biosciences and Diagnostic Solutions to realize its full market […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company’s Board of Directors beginning on February 1, 2025. Dr. Herr will serve on the Science & Technology Committee of the Board of Directors. Dr. Herr is a Chancellor’s Professor of Bioengineering at the […]
All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection 24 replicates to support simultaneous assessment of up to eight conditions per kit Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate […]
Streamlined regulatory documentation accelerates development of next generation therapies SEATTLE — Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its PluriBank™ CG (Clinical Grade) iPSC lines. This comprehensive regulatory submission details […]
Decision Marks a Significant Legal Victory for Parse Biosciences, Reinforcing Commitment to Innovation and Fair Competition SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued Final Written Decisions invalidating […]
ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader of on-target and off-target editing assessment services for cell and gene therapies. This strategic acquisition strengthens MaxCyte’s ability […]
New Kits Offer Broad Antibody Compatibility and Long-Term Stability for Flow Cytometry and Western Blot Applications HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. The new kits offer […]
Long-standing partnership strengthens as both companies target growth in IVD sector CARLSBAD, Calif. — Argonaut Manufacturing Services (“Argonaut”), a leading contract development and manufacturing organization serving the biopharma and life sciences industries, and Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, announced today that Argonaut will act as the manufacturing partner for Akoya’s […]
PARIS — Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its Automated Desktop Organoid Screening Instrument, a high-throughput platform leveraging proprietary microfluidic chips and AI-powered software to accelerate preclinical drug testing and advance functional precision […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
